Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)
Condition(s):Hepatocellular CarcinomaLast Updated:October 23, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Hepatocellular CarcinomaLast Updated:October 23, 2019Completed
Condition(s):Advanced Hepatocellular CarcinomaLast Updated:February 7, 2024Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:September 13, 2023Recruiting
Condition(s):Cirrhosis, Liver; Hepatocellular CarcinomaLast Updated:December 21, 2023Recruiting
Condition(s):Hepatocellular Carcinoma; Hepatitis BLast Updated:January 1, 2014Completed
Condition(s):Hepatocellular CarcinomaLast Updated:April 6, 2021Completed
Condition(s):Hepatocellular Carcinoma, Scirrhous; Recurrence TumorLast Updated:June 6, 2022Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:February 21, 2023Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:February 29, 2024Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:August 2, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.